Cenetri Journals - Policies on Ethics, Conflict of Interest, Human and Animal Rights, and Informed Consent
Publishing of the original research after a firm peer-review process is highly essential for the scientific advancement of society. The quality of a published manuscript adds a significant mark to the authors’ research and the supportive institutions. However, to maintain the quality of these manuscripts, the authors, editors, reviewers, publishers and all the members involved in publishing have to maintain some pre defined ethics.
Conflict of Interest
A Conflict of Interest statement has to be provided by the authors, which is mandatory for all the manuscripts considered for publishing. Authors will be responsible for stating,
- All kinds of support received
from various sources.
- All the institutional and private
funding support received for their study
- Information of all the donors,
who donated the material for the study at free of cost or even at discounted
- Any kind of potential conflict of
interest like patents, ownership etc
- If no funding has been available
other than that of the author's institution, this should be specified upon
Author's conflict of interest or information specifying the absence of conflicts of interest and the sources of funding for the research will be published under a separate heading, "Conflict of Interest Statement".
Human and Animal Rights
Cenetri Journals encourages authors who submit manuscripts reporting from a clinical trial to register the trials registries & bear a clinical trial registration number and the name of the trial. Authors must state the approved protocol for the research project has been approved by the Ethical Committee under which the work was undertaken.
Cenetri Journals hold the right to reject any manuscript on the basis of unethical conduct of either human or animal studies. Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
All investigations that include human subjects should provide a statement that the subject was given an informed consent. Patient confidentiality should be preserved. Photographs and any other records should be cropped sufficiently to prevent human subjects being recognized.
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement (Moher D, Schulz KF, Altman DG: The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials.